[DOI] [PubMed] [Google Scholar] 94.Pollak NM, Jaeger D, Kolleritsch S, Zimmermann R, Zechner R, Lass A, et al
This is because the abdomen generally has higher blood flow to the subcutaneous tissue, pulling medication into systemic circulation faster
And the reason is that the ghrelin itself can impact the growth hormone pathway pretty potently
Compounding involves creating a medication tailored to an individual patients needs, typically when a commercially available drug doesnt meet those needs
Since there is no FDA-approved GHK-Cu drug, responsible physicians inform patients about the uncertain evidence
Check with your HSA/FSA administrator about potential reimbursement options